Fundz
Following Molecular Partners AG?

Get the free weekly contract digest

The latest new contracts, like Molecular Partners AG’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Molecular Partners and Orano Med Strengthen Co-Development Agreement for Radio-DARPin Therapeutics

Oct 22, 2024over 1 year ago

Contract Type

agreement

BiotechnologyTherapeuticsBiopharma

Description

Molecular Partners AG and Orano Med have strengthened their co-development agreement to include the co-development and commercialization of four Radio-DARPin programs. Each company will have the right to commercialize two of the programs, and Molecular Partners will hold commercial rights to the second nominated Radio-DARPin Candidate. The collaboration aims to develop and market Pb-based Radio-DARPin Therapeutics for the treatment of cancer.

Company Information

Company

Molecular Partners AG

About

Molecular Partners AG is a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics.

Predictive Intelligence
Strategic

ML-powered predictions for Molecular Partners AG's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.